Annual report pursuant to Section 13 and 15(d)

EQUITY - Summary of Stock Options Outstanding (Details)

v3.23.1
EQUITY - Summary of Stock Options Outstanding (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Options Outstanding, Options      
Balance at beginning of period (in shares) 20,429,120 9,573,834  
Granted (in shares) 13,686,806 11,486,952  
Exercised (in shares) (324,998) (291,664)  
Cancelled (in shares) (3,038,669) (340,002)  
Balance at end of period (in shares) 30,752,259 20,429,120 9,573,834
Options Outstanding, Weighted Average Exercise Price      
Balance at beginning of period (in dollars per share) $ 3.20 $ 2.00  
Granted (in dollars per share) 1.95 4.16  
Exercised (in dollars per share) 1.67 1.90  
Cancelled (in dollars per share) 4.02 3.23  
Balance at end of period (in dollars per share) $ 2.58 $ 3.20 $ 2.00
Options Outstanding, Additional Disclosures      
Options Outstanding, Aggregate Intrinsic Value, Balance at beginning of period $ 11,583 $ 36,909  
Options Outstanding, Aggregate Intrinsic Value, Exercised 620 881  
Options Outstanding, Aggregate Intrinsic Value, Balance at end of period $ 0 $ 11,583 $ 36,909
Options Outstanding, Weighted Average Remaining Contractual Life 8 years 6 months 8 years 8 months 12 days 8 years 4 months 24 days
Options Exercisable      
Options (in shares) 12,166,594    
Weighted Average Exercise Price (in dollars per share) $ 2.46    
Aggregate Intrinsic Value $ 0    
Weighted Average Remaining Contractual Life 7 years 2 months 12 days